Cargando…

Identification of two new protective pre-erythrocytic malaria vaccine antigen candidates

BACKGROUND: Despite years of effort, a licensed malaria vaccine is not yet available. One of the obstacles facing the development of a malaria vaccine is the extensive heterogeneity of many of the current malaria vaccine antigens. To counteract this antigenic diversity, an effective malaria vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Limbach, Keith, Aguiar, Joao, Gowda, Kalpana, Patterson, Noelle, Abot, Esteban, Sedegah, Martha, Sacci, John, Richie, Thomas
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073953/ https://www.ncbi.nlm.nih.gov/pubmed/21410955 http://dx.doi.org/10.1186/1475-2875-10-65

Ejemplares similares

Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development
por: Aguiar, Joao C., et al.
Publicado: (2015)

Novel malaria antigen Plasmodium yoelii E140 induces antibody-mediated sterile protection in mice against malaria challenge
por: Smith, Emily C., et al.
Publicado: (2020)

New gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model
por: Limbach, Keith, et al.
Publicado: (2017)

Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults
por: Dodoo, Daniel, et al.
Publicado: (2011)

Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens
por: Bettencourt, Paulo
Publicado: (2020)

Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein
por: Speake, Cate, et al.
Publicado: (2016)

Correction: Identification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite Protein
por: Speake, C, et al.
Publicado: (2016)

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming
por: Sedegah, Martha, et al.
Publicado: (2015)

A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults
por: Sklar, Marvin J., et al.
Publicado: (2021)

Sterile Immunity to Malaria after DNA Prime/Adenovirus Boost Immunization Is Associated with Effector Memory CD8+T Cells Targeting AMA1 Class I Epitopes
por: Sedegah, Martha, et al.
Publicado: (2014)

Preliminary characterization of Plasmodium vivax sporozoite antigens as pre-erythrocytic vaccine candidates
por: Nicholas, Justin, et al.
Publicado: (2023)

An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes
por: Ouattara, Amed, et al.
Publicado: (2022)

Surface antigens of Plasmodium falciparum-infected erythrocytes as immune targets and malaria vaccine candidates
por: Chan, Jo-Anne, et al.
Publicado: (2014)

Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
por: Tamminga, Cindy, et al.
Publicado: (2013)

Self-Adjuvanting Bacterial Vectors Expressing Pre-Erythrocytic Antigens Induce Sterile Protection Against Malaria
por: Bergmann-Leitner, Elke S., et al.
Publicado: (2013)

Pre-Erythrocytic Vaccines against Malaria
por: Marques-da-Silva, Camila, et al.
Publicado: (2020)

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01(E) on Blood Stage Immunity in Young Children
por: Bejon, Philip, et al.
Publicado: (2011)

Profiling Humoral Immune Response Against Pre-Erythrocytic and Erythrocytic Antigens of Malaria Parasites Among Neotropical Primates in the Brazilian Atlantic Forest
por: de Assis, Gabriela Maíra Pereira, et al.
Publicado: (2021)

Identification of Pre-Erythrocytic Malaria Antigens That Target Hepatocytes for Killing In Vivo and Contribute to Protection Elicited by Whole-Parasite Vaccination
por: Chen, Lin, et al.
Publicado: (2014)

Antigenicity of the infected-erythrocyte and merozoite surfaces in Falciparum malaria
Publicado: (1979)

Immune Evasion Strategies of Pre-Erythrocytic Malaria Parasites
por: Zheng, Hong, et al.
Publicado: (2014)

Screening of viral-vectored P. falciparum pre-erythrocytic candidate vaccine antigens using chimeric rodent parasites
por: Kolli, Surendra Kumar, et al.
Publicado: (2021)

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA
por: Richie, Thomas L., et al.
Publicado: (2012)

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity
por: Hickey, Bradley W., et al.
Publicado: (2016)

Modeling Combinations of Pre-erythrocytic Plasmodium falciparum Malaria Vaccines
por: Walker, Andrew S., et al.
Publicado: (2015)

Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses
por: Bruder, Joseph T., et al.
Publicado: (2012)

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity
por: Chuang, Ilin, et al.
Publicado: (2013)

Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization
por: Jiang, George, et al.
Publicado: (2007)

Correction: Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses
por: Bruder, Joseph T., et al.
Publicado: (2012)

Tomatine Adjuvantation of Protective Immunity to a Major Pre-erythrocytic Vaccine Candidate of Malaria is Mediated via CD8(+) T Cell Release of IFN-γ
por: Heal, Karen G., et al.
Publicado: (2010)

A probabilistic model of pre-erythrocytic malaria vaccine combination in mice
por: Atcheson, Erwan, et al.
Publicado: (2019)

Adjuvanting a viral vectored vaccine against pre-erythrocytic malaria
por: Milicic, Anita, et al.
Publicado: (2017)

Immune responses to malaria pre-erythrocytic stages: Implications for vaccine development
por: Abuga, Kelvin Mokaya, et al.
Publicado: (2021)

Low immunogenicity of malaria pre‐erythrocytic stages can be overcome by vaccination
por: Müller, Katja, et al.
Publicado: (2021)

Innate immunity limits protective adaptive immune responses against pre-erythrocytic malaria parasites
por: Minkah, Nana K., et al.
Publicado: (2019)

Surface alterations of erythrocytes in Plasmodium falciparum malaria. Antigenic variation, antigenic diversity, and the role of the spleen
Publicado: (1983)

Induction of antigen specific intrahepatic CD8+ T cell responses by a secreted heat shock protein based gp96-Ig-PfCA malaria vaccine
por: Padula, Laura, et al.
Publicado: (2023)

Development of an in vitro Plasmodium parasite killing assay for the evaluation of cell-mediated immune responses following vaccination with pre-erythrocytic malaria vaccine candidates
por: Bliss, Carly M, et al.
Publicado: (2014)

Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8(+) T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vectored malaria vaccine expressing AMA1
por: Schwenk, Robert, et al.
Publicado: (2013)

Transcriptional Analysis of the Pre-Erythrocytic Stages of the Rodent Malaria Parasite, Plasmodium yoelii
por: Williams, Calvin T., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_onu18uih1klv3t00vvm5hfupqr